623 related articles for article (PubMed ID: 8104645)
1. Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.
Sillence MN; Moore NG; Pegg GG; Lindsay DB
Br J Pharmacol; 1993 Aug; 109(4):1157-63. PubMed ID: 8104645
[TBL] [Abstract][Full Text] [Related]
2. Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.
Sillence MN; Matthews ML
Br J Pharmacol; 1994 Mar; 111(3):866-72. PubMed ID: 7912629
[TBL] [Abstract][Full Text] [Related]
3. Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.
Roberts SJ; Molenaar P; Summers RJ
Br J Pharmacol; 1993 Jun; 109(2):344-52. PubMed ID: 8102926
[TBL] [Abstract][Full Text] [Related]
4. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
5. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
Bjørnerheim R; Golf S; Hansson V
Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
[TBL] [Abstract][Full Text] [Related]
6. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat.
D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ
Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727
[TBL] [Abstract][Full Text] [Related]
7. Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.
Hoey A; Jackson C; Pegg G; Sillence M
Br J Pharmacol; 1996 Feb; 117(4):712-6. PubMed ID: 8646418
[TBL] [Abstract][Full Text] [Related]
8. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
Kaumann AJ; Molenaar P
Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
[TBL] [Abstract][Full Text] [Related]
9. ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
Brahmadevara N; Shaw AM; MacDonald A
Br J Pharmacol; 2004 Jun; 142(4):781-7. PubMed ID: 15205310
[TBL] [Abstract][Full Text] [Related]
10. Characterization of beta-adrenoceptors responsible for venom production in the venom gland of the snake Bothrops jararaca.
Yamanouye N; Carneiro SM; Scrivano CN; Markus RP
Life Sci; 2000 Jun; 67(3):217-26. PubMed ID: 10983865
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rat cerebral cortical beta adrenoceptor subtypes using (-)-[125I]-iodocyanopindolol.
Tiong AH; Richardson JS
J Recept Res; 1989-1990; 9(6):495-508. PubMed ID: 2577008
[TBL] [Abstract][Full Text] [Related]
12. Labelling of rat brain beta-adrenoceptors: (3H)CGP-12177 or (125I)iodocyanopindolol?
Morin D; Zini R; Urien S; Sapena R; Tillement JP
J Recept Res; 1992; 12(3):369-87. PubMed ID: 1354747
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterisation of beta-adrenoceptors on intact equine peripheral blood lymphocytes with the radioligand (-)-[125I]-iodocyanopindolol.
Abraham G; Broddet OE; Ungemach FR
Equine Vet J; 2001 Sep; 33(5):487-93. PubMed ID: 11558744
[TBL] [Abstract][Full Text] [Related]
14. Characterization of beta 1- and beta 2-adrenoceptors in rat skeletal muscles.
Kim YS; Sainz RD; Molenaar P; Summers RJ
Biochem Pharmacol; 1991 Oct; 42(9):1783-9. PubMed ID: 1681810
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
Tsuchihashi H; Nakashima Y; Kinami J; Nagatomo T
Jpn J Pharmacol; 1990 Feb; 52(2):195-200. PubMed ID: 1968985
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenoceptor subtype expression and function in rat white adipocytes.
Germack R; Starzec AB; Vassy R; Perret GY
Br J Pharmacol; 1997 Jan; 120(2):201-10. PubMed ID: 9117110
[TBL] [Abstract][Full Text] [Related]
17. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
Sarsero D; Molenaar P; Kaumann AJ
Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
[TBL] [Abstract][Full Text] [Related]
18. Three binding sites of 125I-iodocyanopindolol, i.e. beta 1, beta 2-adrenergic and 5HT1B-serotonergic receptors in rat brain determined by the displacement and Scatchard analysis.
Tsuchihashi H; Nagatomo T; Imai S
J Pharmacobiodyn; 1989 Sep; 12(9):509-16. PubMed ID: 2559184
[TBL] [Abstract][Full Text] [Related]
19. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
[TBL] [Abstract][Full Text] [Related]
20. The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands.
Nanoff C; Freissmuth M; Schütz W
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):519-25. PubMed ID: 2893983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
